Aquatrove Biosciences, Inc. presented positive results from a study demonstrating that the technology used in Conceive Plus™ may assist trying to conceive couples. These data were recently presented at the 65th Annual Meeting of the American Society for Reproductive Medicine (ASRM).
This preclinical study was designed to measure the impact of Aquatrove’s novel calcium and magnesium containing vaginal lubricants on sperm motility, viability, and function. Results demonstrated that the lubricant technology developed by Aquatrove successfully supplies essential ions critical to fertilization and indicated that it does not interfere with sperm viability or function. This is a key differentiating factor among marketed lubricants, as the formulation of many other products hinder the ability of sperm to survive or move, thereby interfering with a couple’s capability to conceive. Aquatrove’s data also shows that this novel calcium and magnesium containing lubricant does not harm mammalian embryos. By closely resembling the body’s natural environment, the Aquatrove lubricant technology helps to create a conception friendly environment by removing barriers for couples trying to conceive.
The novel lubricant technology developed by Aquatrove is available commercially as Conceive Plus™. Conceive Plus™ is manufactured and distributed by SASMAR and is available to consumers worldwide now at many leading pharmacies or online at www.conceiveplus.com.
Calcium channel blockers show potential to restore cerebral blood flow in Alzheimer's disease